Global Monoclonal Antibody Drug Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Monoclonal Antibody Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Monoclonal Antibody Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Monoclonal Antibody Drug market in any manner.
Global Monoclonal Antibody Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott
Johnson & Johnson
Roche
Ono Pharmaceutical
Amgen
Merck
Jiangsu Hengrui Pharmaceuticals
Beigene
Shanghai Junshi Biosciences
Innovent Biologics
WuXi Biologics (Cayman)
Shanghai Henlius Biotech
Akeso
Lepu Biopharma
CStone Pharmaceuticals
Hillhouse Investment Management
Alphamab Oncology
Novartis
Takeda Pharmaceutical
Market Segmentation (by Type)
Humanized Monoclonal Antibody Drugs
Fully Human Monoclonal Antibody Drugs
Small Molecule Antibody Drugs
Chimeric Monoclonal Antibody Drugs
Other
Market Segmentation (by Application)
Cancer Treatment
Autoimmune Disease Treatment
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Monoclonal Antibody Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Monoclonal Antibody Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Monoclonal Antibody Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Monoclonal Antibody Drug market in any manner.
Global Monoclonal Antibody Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott
Johnson & Johnson
Roche
Ono Pharmaceutical
Amgen
Merck
Jiangsu Hengrui Pharmaceuticals
Beigene
Shanghai Junshi Biosciences
Innovent Biologics
WuXi Biologics (Cayman)
Shanghai Henlius Biotech
Akeso
Lepu Biopharma
CStone Pharmaceuticals
Hillhouse Investment Management
Alphamab Oncology
Novartis
Takeda Pharmaceutical
Market Segmentation (by Type)
Humanized Monoclonal Antibody Drugs
Fully Human Monoclonal Antibody Drugs
Small Molecule Antibody Drugs
Chimeric Monoclonal Antibody Drugs
Other
Market Segmentation (by Application)
Cancer Treatment
Autoimmune Disease Treatment
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Monoclonal Antibody Drug Market
- Overview of the regional outlook of the Monoclonal Antibody Drug Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Monoclonal Antibody Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Monoclonal Antibody Drug
1.2 Key Market Segments
1.2.1 Monoclonal Antibody Drug Segment by Type
1.2.2 Monoclonal Antibody Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MONOCLONAL ANTIBODY DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Monoclonal Antibody Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Monoclonal Antibody Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MONOCLONAL ANTIBODY DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Monoclonal Antibody Drug Sales by Manufacturers (2019-2024)
3.2 Global Monoclonal Antibody Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Monoclonal Antibody Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Monoclonal Antibody Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Monoclonal Antibody Drug Sales Sites, Area Served, Product Type
3.6 Monoclonal Antibody Drug Market Competitive Situation and Trends
3.6.1 Monoclonal Antibody Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Monoclonal Antibody Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MONOCLONAL ANTIBODY DRUG INDUSTRY CHAIN ANALYSIS
4.1 Monoclonal Antibody Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MONOCLONAL ANTIBODY DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MONOCLONAL ANTIBODY DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Monoclonal Antibody Drug Sales Market Share by Type (2019-2024)
6.3 Global Monoclonal Antibody Drug Market Size Market Share by Type (2019-2024)
6.4 Global Monoclonal Antibody Drug Price by Type (2019-2024)
7 MONOCLONAL ANTIBODY DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Monoclonal Antibody Drug Market Sales by Application (2019-2024)
7.3 Global Monoclonal Antibody Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Monoclonal Antibody Drug Sales Growth Rate by Application (2019-2024)
8 MONOCLONAL ANTIBODY DRUG MARKET SEGMENTATION BY REGION
8.1 Global Monoclonal Antibody Drug Sales by Region
8.1.1 Global Monoclonal Antibody Drug Sales by Region
8.1.2 Global Monoclonal Antibody Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Monoclonal Antibody Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Monoclonal Antibody Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Monoclonal Antibody Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Monoclonal Antibody Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Monoclonal Antibody Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott
9.1.1 Abbott Monoclonal Antibody Drug Basic Information
9.1.2 Abbott Monoclonal Antibody Drug Product Overview
9.1.3 Abbott Monoclonal Antibody Drug Product Market Performance
9.1.4 Abbott Business Overview
9.1.5 Abbott Monoclonal Antibody Drug SWOT Analysis
9.1.6 Abbott Recent Developments
9.2 Johnson and Johnson
9.2.1 Johnson and Johnson Monoclonal Antibody Drug Basic Information
9.2.2 Johnson and Johnson Monoclonal Antibody Drug Product Overview
9.2.3 Johnson and Johnson Monoclonal Antibody Drug Product Market Performance
9.2.4 Johnson and Johnson Business Overview
9.2.5 Johnson and Johnson Monoclonal Antibody Drug SWOT Analysis
9.2.6 Johnson and Johnson Recent Developments
9.3 Roche
9.3.1 Roche Monoclonal Antibody Drug Basic Information
9.3.2 Roche Monoclonal Antibody Drug Product Overview
9.3.3 Roche Monoclonal Antibody Drug Product Market Performance
9.3.4 Roche Monoclonal Antibody Drug SWOT Analysis
9.3.5 Roche Business Overview
9.3.6 Roche Recent Developments
9.4 Ono Pharmaceutical
9.4.1 Ono Pharmaceutical Monoclonal Antibody Drug Basic Information
9.4.2 Ono Pharmaceutical Monoclonal Antibody Drug Product Overview
9.4.3 Ono Pharmaceutical Monoclonal Antibody Drug Product Market Performance
9.4.4 Ono Pharmaceutical Business Overview
9.4.5 Ono Pharmaceutical Recent Developments
9.5 Amgen
9.5.1 Amgen Monoclonal Antibody Drug Basic Information
9.5.2 Amgen Monoclonal Antibody Drug Product Overview
9.5.3 Amgen Monoclonal Antibody Drug Product Market Performance
9.5.4 Amgen Business Overview
9.5.5 Amgen Recent Developments
9.6 Merck
9.6.1 Merck Monoclonal Antibody Drug Basic Information
9.6.2 Merck Monoclonal Antibody Drug Product Overview
9.6.3 Merck Monoclonal Antibody Drug Product Market Performance
9.6.4 Merck Business Overview
9.6.5 Merck Recent Developments
9.7 Jiangsu Hengrui Pharmaceuticals
9.7.1 Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Basic Information
9.7.2 Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Product Overview
9.7.3 Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Product Market Performance
9.7.4 Jiangsu Hengrui Pharmaceuticals Business Overview
9.7.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
9.8 Beigene
9.8.1 Beigene Monoclonal Antibody Drug Basic Information
9.8.2 Beigene Monoclonal Antibody Drug Product Overview
9.8.3 Beigene Monoclonal Antibody Drug Product Market Performance
9.8.4 Beigene Business Overview
9.8.5 Beigene Recent Developments
9.9 Shanghai Junshi Biosciences
9.9.1 Shanghai Junshi Biosciences Monoclonal Antibody Drug Basic Information
9.9.2 Shanghai Junshi Biosciences Monoclonal Antibody Drug Product Overview
9.9.3 Shanghai Junshi Biosciences Monoclonal Antibody Drug Product Market Performance
9.9.4 Shanghai Junshi Biosciences Business Overview
9.9.5 Shanghai Junshi Biosciences Recent Developments
9.10 Innovent Biologics
9.10.1 Innovent Biologics Monoclonal Antibody Drug Basic Information
9.10.2 Innovent Biologics Monoclonal Antibody Drug Product Overview
9.10.3 Innovent Biologics Monoclonal Antibody Drug Product Market Performance
9.10.4 Innovent Biologics Business Overview
9.10.5 Innovent Biologics Recent Developments
9.11 WuXi Biologics (Cayman)
9.11.1 WuXi Biologics (Cayman) Monoclonal Antibody Drug Basic Information
9.11.2 WuXi Biologics (Cayman) Monoclonal Antibody Drug Product Overview
9.11.3 WuXi Biologics (Cayman) Monoclonal Antibody Drug Product Market Performance
9.11.4 WuXi Biologics (Cayman) Business Overview
9.11.5 WuXi Biologics (Cayman) Recent Developments
9.12 Shanghai Henlius Biotech
9.12.1 Shanghai Henlius Biotech Monoclonal Antibody Drug Basic Information
9.12.2 Shanghai Henlius Biotech Monoclonal Antibody Drug Product Overview
9.12.3 Shanghai Henlius Biotech Monoclonal Antibody Drug Product Market Performance
9.12.4 Shanghai Henlius Biotech Business Overview
9.12.5 Shanghai Henlius Biotech Recent Developments
9.13 Akeso
9.13.1 Akeso Monoclonal Antibody Drug Basic Information
9.13.2 Akeso Monoclonal Antibody Drug Product Overview
9.13.3 Akeso Monoclonal Antibody Drug Product Market Performance
9.13.4 Akeso Business Overview
9.13.5 Akeso Recent Developments
9.14 Lepu Biopharma
9.14.1 Lepu Biopharma Monoclonal Antibody Drug Basic Information
9.14.2 Lepu Biopharma Monoclonal Antibody Drug Product Overview
9.14.3 Lepu Biopharma Monoclonal Antibody Drug Product Market Performance
9.14.4 Lepu Biopharma Business Overview
9.14.5 Lepu Biopharma Recent Developments
9.15 CStone Pharmaceuticals
9.15.1 CStone Pharmaceuticals Monoclonal Antibody Drug Basic Information
9.15.2 CStone Pharmaceuticals Monoclonal Antibody Drug Product Overview
9.15.3 CStone Pharmaceuticals Monoclonal Antibody Drug Product Market Performance
9.15.4 CStone Pharmaceuticals Business Overview
9.15.5 CStone Pharmaceuticals Recent Developments
9.16 Hillhouse Investment Management
9.16.1 Hillhouse Investment Management Monoclonal Antibody Drug Basic Information
9.16.2 Hillhouse Investment Management Monoclonal Antibody Drug Product Overview
9.16.3 Hillhouse Investment Management Monoclonal Antibody Drug Product Market Performance
9.16.4 Hillhouse Investment Management Business Overview
9.16.5 Hillhouse Investment Management Recent Developments
9.17 Alphamab Oncology
9.17.1 Alphamab Oncology Monoclonal Antibody Drug Basic Information
9.17.2 Alphamab Oncology Monoclonal Antibody Drug Product Overview
9.17.3 Alphamab Oncology Monoclonal Antibody Drug Product Market Performance
9.17.4 Alphamab Oncology Business Overview
9.17.5 Alphamab Oncology Recent Developments
9.18 Novartis
9.18.1 Novartis Monoclonal Antibody Drug Basic Information
9.18.2 Novartis Monoclonal Antibody Drug Product Overview
9.18.3 Novartis Monoclonal Antibody Drug Product Market Performance
9.18.4 Novartis Business Overview
9.18.5 Novartis Recent Developments
9.19 Takeda Pharmaceutical
9.19.1 Takeda Pharmaceutical Monoclonal Antibody Drug Basic Information
9.19.2 Takeda Pharmaceutical Monoclonal Antibody Drug Product Overview
9.19.3 Takeda Pharmaceutical Monoclonal Antibody Drug Product Market Performance
9.19.4 Takeda Pharmaceutical Business Overview
9.19.5 Takeda Pharmaceutical Recent Developments
10 MONOCLONAL ANTIBODY DRUG MARKET FORECAST BY REGION
10.1 Global Monoclonal Antibody Drug Market Size Forecast
10.2 Global Monoclonal Antibody Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Monoclonal Antibody Drug Market Size Forecast by Country
10.2.3 Asia Pacific Monoclonal Antibody Drug Market Size Forecast by Region
10.2.4 South America Monoclonal Antibody Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Monoclonal Antibody Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Monoclonal Antibody Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Monoclonal Antibody Drug by Type (2025-2030)
11.1.2 Global Monoclonal Antibody Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Monoclonal Antibody Drug by Type (2025-2030)
11.2 Global Monoclonal Antibody Drug Market Forecast by Application (2025-2030)
11.2.1 Global Monoclonal Antibody Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Monoclonal Antibody Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Monoclonal Antibody Drug
1.2 Key Market Segments
1.2.1 Monoclonal Antibody Drug Segment by Type
1.2.2 Monoclonal Antibody Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MONOCLONAL ANTIBODY DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Monoclonal Antibody Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Monoclonal Antibody Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MONOCLONAL ANTIBODY DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Monoclonal Antibody Drug Sales by Manufacturers (2019-2024)
3.2 Global Monoclonal Antibody Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Monoclonal Antibody Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Monoclonal Antibody Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Monoclonal Antibody Drug Sales Sites, Area Served, Product Type
3.6 Monoclonal Antibody Drug Market Competitive Situation and Trends
3.6.1 Monoclonal Antibody Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Monoclonal Antibody Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MONOCLONAL ANTIBODY DRUG INDUSTRY CHAIN ANALYSIS
4.1 Monoclonal Antibody Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MONOCLONAL ANTIBODY DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MONOCLONAL ANTIBODY DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Monoclonal Antibody Drug Sales Market Share by Type (2019-2024)
6.3 Global Monoclonal Antibody Drug Market Size Market Share by Type (2019-2024)
6.4 Global Monoclonal Antibody Drug Price by Type (2019-2024)
7 MONOCLONAL ANTIBODY DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Monoclonal Antibody Drug Market Sales by Application (2019-2024)
7.3 Global Monoclonal Antibody Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Monoclonal Antibody Drug Sales Growth Rate by Application (2019-2024)
8 MONOCLONAL ANTIBODY DRUG MARKET SEGMENTATION BY REGION
8.1 Global Monoclonal Antibody Drug Sales by Region
8.1.1 Global Monoclonal Antibody Drug Sales by Region
8.1.2 Global Monoclonal Antibody Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Monoclonal Antibody Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Monoclonal Antibody Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Monoclonal Antibody Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Monoclonal Antibody Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Monoclonal Antibody Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott
9.1.1 Abbott Monoclonal Antibody Drug Basic Information
9.1.2 Abbott Monoclonal Antibody Drug Product Overview
9.1.3 Abbott Monoclonal Antibody Drug Product Market Performance
9.1.4 Abbott Business Overview
9.1.5 Abbott Monoclonal Antibody Drug SWOT Analysis
9.1.6 Abbott Recent Developments
9.2 Johnson and Johnson
9.2.1 Johnson and Johnson Monoclonal Antibody Drug Basic Information
9.2.2 Johnson and Johnson Monoclonal Antibody Drug Product Overview
9.2.3 Johnson and Johnson Monoclonal Antibody Drug Product Market Performance
9.2.4 Johnson and Johnson Business Overview
9.2.5 Johnson and Johnson Monoclonal Antibody Drug SWOT Analysis
9.2.6 Johnson and Johnson Recent Developments
9.3 Roche
9.3.1 Roche Monoclonal Antibody Drug Basic Information
9.3.2 Roche Monoclonal Antibody Drug Product Overview
9.3.3 Roche Monoclonal Antibody Drug Product Market Performance
9.3.4 Roche Monoclonal Antibody Drug SWOT Analysis
9.3.5 Roche Business Overview
9.3.6 Roche Recent Developments
9.4 Ono Pharmaceutical
9.4.1 Ono Pharmaceutical Monoclonal Antibody Drug Basic Information
9.4.2 Ono Pharmaceutical Monoclonal Antibody Drug Product Overview
9.4.3 Ono Pharmaceutical Monoclonal Antibody Drug Product Market Performance
9.4.4 Ono Pharmaceutical Business Overview
9.4.5 Ono Pharmaceutical Recent Developments
9.5 Amgen
9.5.1 Amgen Monoclonal Antibody Drug Basic Information
9.5.2 Amgen Monoclonal Antibody Drug Product Overview
9.5.3 Amgen Monoclonal Antibody Drug Product Market Performance
9.5.4 Amgen Business Overview
9.5.5 Amgen Recent Developments
9.6 Merck
9.6.1 Merck Monoclonal Antibody Drug Basic Information
9.6.2 Merck Monoclonal Antibody Drug Product Overview
9.6.3 Merck Monoclonal Antibody Drug Product Market Performance
9.6.4 Merck Business Overview
9.6.5 Merck Recent Developments
9.7 Jiangsu Hengrui Pharmaceuticals
9.7.1 Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Basic Information
9.7.2 Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Product Overview
9.7.3 Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Product Market Performance
9.7.4 Jiangsu Hengrui Pharmaceuticals Business Overview
9.7.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
9.8 Beigene
9.8.1 Beigene Monoclonal Antibody Drug Basic Information
9.8.2 Beigene Monoclonal Antibody Drug Product Overview
9.8.3 Beigene Monoclonal Antibody Drug Product Market Performance
9.8.4 Beigene Business Overview
9.8.5 Beigene Recent Developments
9.9 Shanghai Junshi Biosciences
9.9.1 Shanghai Junshi Biosciences Monoclonal Antibody Drug Basic Information
9.9.2 Shanghai Junshi Biosciences Monoclonal Antibody Drug Product Overview
9.9.3 Shanghai Junshi Biosciences Monoclonal Antibody Drug Product Market Performance
9.9.4 Shanghai Junshi Biosciences Business Overview
9.9.5 Shanghai Junshi Biosciences Recent Developments
9.10 Innovent Biologics
9.10.1 Innovent Biologics Monoclonal Antibody Drug Basic Information
9.10.2 Innovent Biologics Monoclonal Antibody Drug Product Overview
9.10.3 Innovent Biologics Monoclonal Antibody Drug Product Market Performance
9.10.4 Innovent Biologics Business Overview
9.10.5 Innovent Biologics Recent Developments
9.11 WuXi Biologics (Cayman)
9.11.1 WuXi Biologics (Cayman) Monoclonal Antibody Drug Basic Information
9.11.2 WuXi Biologics (Cayman) Monoclonal Antibody Drug Product Overview
9.11.3 WuXi Biologics (Cayman) Monoclonal Antibody Drug Product Market Performance
9.11.4 WuXi Biologics (Cayman) Business Overview
9.11.5 WuXi Biologics (Cayman) Recent Developments
9.12 Shanghai Henlius Biotech
9.12.1 Shanghai Henlius Biotech Monoclonal Antibody Drug Basic Information
9.12.2 Shanghai Henlius Biotech Monoclonal Antibody Drug Product Overview
9.12.3 Shanghai Henlius Biotech Monoclonal Antibody Drug Product Market Performance
9.12.4 Shanghai Henlius Biotech Business Overview
9.12.5 Shanghai Henlius Biotech Recent Developments
9.13 Akeso
9.13.1 Akeso Monoclonal Antibody Drug Basic Information
9.13.2 Akeso Monoclonal Antibody Drug Product Overview
9.13.3 Akeso Monoclonal Antibody Drug Product Market Performance
9.13.4 Akeso Business Overview
9.13.5 Akeso Recent Developments
9.14 Lepu Biopharma
9.14.1 Lepu Biopharma Monoclonal Antibody Drug Basic Information
9.14.2 Lepu Biopharma Monoclonal Antibody Drug Product Overview
9.14.3 Lepu Biopharma Monoclonal Antibody Drug Product Market Performance
9.14.4 Lepu Biopharma Business Overview
9.14.5 Lepu Biopharma Recent Developments
9.15 CStone Pharmaceuticals
9.15.1 CStone Pharmaceuticals Monoclonal Antibody Drug Basic Information
9.15.2 CStone Pharmaceuticals Monoclonal Antibody Drug Product Overview
9.15.3 CStone Pharmaceuticals Monoclonal Antibody Drug Product Market Performance
9.15.4 CStone Pharmaceuticals Business Overview
9.15.5 CStone Pharmaceuticals Recent Developments
9.16 Hillhouse Investment Management
9.16.1 Hillhouse Investment Management Monoclonal Antibody Drug Basic Information
9.16.2 Hillhouse Investment Management Monoclonal Antibody Drug Product Overview
9.16.3 Hillhouse Investment Management Monoclonal Antibody Drug Product Market Performance
9.16.4 Hillhouse Investment Management Business Overview
9.16.5 Hillhouse Investment Management Recent Developments
9.17 Alphamab Oncology
9.17.1 Alphamab Oncology Monoclonal Antibody Drug Basic Information
9.17.2 Alphamab Oncology Monoclonal Antibody Drug Product Overview
9.17.3 Alphamab Oncology Monoclonal Antibody Drug Product Market Performance
9.17.4 Alphamab Oncology Business Overview
9.17.5 Alphamab Oncology Recent Developments
9.18 Novartis
9.18.1 Novartis Monoclonal Antibody Drug Basic Information
9.18.2 Novartis Monoclonal Antibody Drug Product Overview
9.18.3 Novartis Monoclonal Antibody Drug Product Market Performance
9.18.4 Novartis Business Overview
9.18.5 Novartis Recent Developments
9.19 Takeda Pharmaceutical
9.19.1 Takeda Pharmaceutical Monoclonal Antibody Drug Basic Information
9.19.2 Takeda Pharmaceutical Monoclonal Antibody Drug Product Overview
9.19.3 Takeda Pharmaceutical Monoclonal Antibody Drug Product Market Performance
9.19.4 Takeda Pharmaceutical Business Overview
9.19.5 Takeda Pharmaceutical Recent Developments
10 MONOCLONAL ANTIBODY DRUG MARKET FORECAST BY REGION
10.1 Global Monoclonal Antibody Drug Market Size Forecast
10.2 Global Monoclonal Antibody Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Monoclonal Antibody Drug Market Size Forecast by Country
10.2.3 Asia Pacific Monoclonal Antibody Drug Market Size Forecast by Region
10.2.4 South America Monoclonal Antibody Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Monoclonal Antibody Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Monoclonal Antibody Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Monoclonal Antibody Drug by Type (2025-2030)
11.1.2 Global Monoclonal Antibody Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Monoclonal Antibody Drug by Type (2025-2030)
11.2 Global Monoclonal Antibody Drug Market Forecast by Application (2025-2030)
11.2.1 Global Monoclonal Antibody Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Monoclonal Antibody Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Monoclonal Antibody Drug Market Size Comparison by Region (M USD)
Table 5. Global Monoclonal Antibody Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Monoclonal Antibody Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Monoclonal Antibody Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Monoclonal Antibody Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Drug as of 2022)
Table 10. Global Market Monoclonal Antibody Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Monoclonal Antibody Drug Sales Sites and Area Served
Table 12. Manufacturers Monoclonal Antibody Drug Product Type
Table 13. Global Monoclonal Antibody Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Monoclonal Antibody Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Monoclonal Antibody Drug Market Challenges
Table 22. Global Monoclonal Antibody Drug Sales by Type (Kilotons)
Table 23. Global Monoclonal Antibody Drug Market Size by Type (M USD)
Table 24. Global Monoclonal Antibody Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Monoclonal Antibody Drug Sales Market Share by Type (2019-2024)
Table 26. Global Monoclonal Antibody Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Monoclonal Antibody Drug Market Size Share by Type (2019-2024)
Table 28. Global Monoclonal Antibody Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Monoclonal Antibody Drug Sales (Kilotons) by Application
Table 30. Global Monoclonal Antibody Drug Market Size by Application
Table 31. Global Monoclonal Antibody Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Monoclonal Antibody Drug Sales Market Share by Application (2019-2024)
Table 33. Global Monoclonal Antibody Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Monoclonal Antibody Drug Market Share by Application (2019-2024)
Table 35. Global Monoclonal Antibody Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Monoclonal Antibody Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Monoclonal Antibody Drug Sales Market Share by Region (2019-2024)
Table 38. North America Monoclonal Antibody Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Monoclonal Antibody Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Monoclonal Antibody Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Monoclonal Antibody Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Monoclonal Antibody Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Abbott Monoclonal Antibody Drug Basic Information
Table 44. Abbott Monoclonal Antibody Drug Product Overview
Table 45. Abbott Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Abbott Business Overview
Table 47. Abbott Monoclonal Antibody Drug SWOT Analysis
Table 48. Abbott Recent Developments
Table 49. Johnson and Johnson Monoclonal Antibody Drug Basic Information
Table 50. Johnson and Johnson Monoclonal Antibody Drug Product Overview
Table 51. Johnson and Johnson Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Johnson and Johnson Business Overview
Table 53. Johnson and Johnson Monoclonal Antibody Drug SWOT Analysis
Table 54. Johnson and Johnson Recent Developments
Table 55. Roche Monoclonal Antibody Drug Basic Information
Table 56. Roche Monoclonal Antibody Drug Product Overview
Table 57. Roche Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Roche Monoclonal Antibody Drug SWOT Analysis
Table 59. Roche Business Overview
Table 60. Roche Recent Developments
Table 61. Ono Pharmaceutical Monoclonal Antibody Drug Basic Information
Table 62. Ono Pharmaceutical Monoclonal Antibody Drug Product Overview
Table 63. Ono Pharmaceutical Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Ono Pharmaceutical Business Overview
Table 65. Ono Pharmaceutical Recent Developments
Table 66. Amgen Monoclonal Antibody Drug Basic Information
Table 67. Amgen Monoclonal Antibody Drug Product Overview
Table 68. Amgen Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Amgen Business Overview
Table 70. Amgen Recent Developments
Table 71. Merck Monoclonal Antibody Drug Basic Information
Table 72. Merck Monoclonal Antibody Drug Product Overview
Table 73. Merck Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Merck Business Overview
Table 75. Merck Recent Developments
Table 76. Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Basic Information
Table 77. Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Product Overview
Table 78. Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Jiangsu Hengrui Pharmaceuticals Business Overview
Table 80. Jiangsu Hengrui Pharmaceuticals Recent Developments
Table 81. Beigene Monoclonal Antibody Drug Basic Information
Table 82. Beigene Monoclonal Antibody Drug Product Overview
Table 83. Beigene Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Beigene Business Overview
Table 85. Beigene Recent Developments
Table 86. Shanghai Junshi Biosciences Monoclonal Antibody Drug Basic Information
Table 87. Shanghai Junshi Biosciences Monoclonal Antibody Drug Product Overview
Table 88. Shanghai Junshi Biosciences Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Shanghai Junshi Biosciences Business Overview
Table 90. Shanghai Junshi Biosciences Recent Developments
Table 91. Innovent Biologics Monoclonal Antibody Drug Basic Information
Table 92. Innovent Biologics Monoclonal Antibody Drug Product Overview
Table 93. Innovent Biologics Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Innovent Biologics Business Overview
Table 95. Innovent Biologics Recent Developments
Table 96. WuXi Biologics (Cayman) Monoclonal Antibody Drug Basic Information
Table 97. WuXi Biologics (Cayman) Monoclonal Antibody Drug Product Overview
Table 98. WuXi Biologics (Cayman) Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. WuXi Biologics (Cayman) Business Overview
Table 100. WuXi Biologics (Cayman) Recent Developments
Table 101. Shanghai Henlius Biotech Monoclonal Antibody Drug Basic Information
Table 102. Shanghai Henlius Biotech Monoclonal Antibody Drug Product Overview
Table 103. Shanghai Henlius Biotech Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Shanghai Henlius Biotech Business Overview
Table 105. Shanghai Henlius Biotech Recent Developments
Table 106. Akeso Monoclonal Antibody Drug Basic Information
Table 107. Akeso Monoclonal Antibody Drug Product Overview
Table 108. Akeso Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Akeso Business Overview
Table 110. Akeso Recent Developments
Table 111. Lepu Biopharma Monoclonal Antibody Drug Basic Information
Table 112. Lepu Biopharma Monoclonal Antibody Drug Product Overview
Table 113. Lepu Biopharma Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Lepu Biopharma Business Overview
Table 115. Lepu Biopharma Recent Developments
Table 116. CStone Pharmaceuticals Monoclonal Antibody Drug Basic Information
Table 117. CStone Pharmaceuticals Monoclonal Antibody Drug Product Overview
Table 118. CStone Pharmaceuticals Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. CStone Pharmaceuticals Business Overview
Table 120. CStone Pharmaceuticals Recent Developments
Table 121. Hillhouse Investment Management Monoclonal Antibody Drug Basic Information
Table 122. Hillhouse Investment Management Monoclonal Antibody Drug Product Overview
Table 123. Hillhouse Investment Management Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Hillhouse Investment Management Business Overview
Table 125. Hillhouse Investment Management Recent Developments
Table 126. Alphamab Oncology Monoclonal Antibody Drug Basic Information
Table 127. Alphamab Oncology Monoclonal Antibody Drug Product Overview
Table 128. Alphamab Oncology Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Alphamab Oncology Business Overview
Table 130. Alphamab Oncology Recent Developments
Table 131. Novartis Monoclonal Antibody Drug Basic Information
Table 132. Novartis Monoclonal Antibody Drug Product Overview
Table 133. Novartis Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Novartis Business Overview
Table 135. Novartis Recent Developments
Table 136. Takeda Pharmaceutical Monoclonal Antibody Drug Basic Information
Table 137. Takeda Pharmaceutical Monoclonal Antibody Drug Product Overview
Table 138. Takeda Pharmaceutical Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Takeda Pharmaceutical Business Overview
Table 140. Takeda Pharmaceutical Recent Developments
Table 141. Global Monoclonal Antibody Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 142. Global Monoclonal Antibody Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 143. North America Monoclonal Antibody Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 144. North America Monoclonal Antibody Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 145. Europe Monoclonal Antibody Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 146. Europe Monoclonal Antibody Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Asia Pacific Monoclonal Antibody Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 148. Asia Pacific Monoclonal Antibody Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 149. South America Monoclonal Antibody Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 150. South America Monoclonal Antibody Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 151. Middle East and Africa Monoclonal Antibody Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 152. Middle East and Africa Monoclonal Antibody Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 153. Global Monoclonal Antibody Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 154. Global Monoclonal Antibody Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 155. Global Monoclonal Antibody Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 156. Global Monoclonal Antibody Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 157. Global Monoclonal Antibody Drug Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Monoclonal Antibody Drug Market Size Comparison by Region (M USD)
Table 5. Global Monoclonal Antibody Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Monoclonal Antibody Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Monoclonal Antibody Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Monoclonal Antibody Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Drug as of 2022)
Table 10. Global Market Monoclonal Antibody Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Monoclonal Antibody Drug Sales Sites and Area Served
Table 12. Manufacturers Monoclonal Antibody Drug Product Type
Table 13. Global Monoclonal Antibody Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Monoclonal Antibody Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Monoclonal Antibody Drug Market Challenges
Table 22. Global Monoclonal Antibody Drug Sales by Type (Kilotons)
Table 23. Global Monoclonal Antibody Drug Market Size by Type (M USD)
Table 24. Global Monoclonal Antibody Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Monoclonal Antibody Drug Sales Market Share by Type (2019-2024)
Table 26. Global Monoclonal Antibody Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Monoclonal Antibody Drug Market Size Share by Type (2019-2024)
Table 28. Global Monoclonal Antibody Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Monoclonal Antibody Drug Sales (Kilotons) by Application
Table 30. Global Monoclonal Antibody Drug Market Size by Application
Table 31. Global Monoclonal Antibody Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Monoclonal Antibody Drug Sales Market Share by Application (2019-2024)
Table 33. Global Monoclonal Antibody Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Monoclonal Antibody Drug Market Share by Application (2019-2024)
Table 35. Global Monoclonal Antibody Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Monoclonal Antibody Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Monoclonal Antibody Drug Sales Market Share by Region (2019-2024)
Table 38. North America Monoclonal Antibody Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Monoclonal Antibody Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Monoclonal Antibody Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Monoclonal Antibody Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Monoclonal Antibody Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Abbott Monoclonal Antibody Drug Basic Information
Table 44. Abbott Monoclonal Antibody Drug Product Overview
Table 45. Abbott Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Abbott Business Overview
Table 47. Abbott Monoclonal Antibody Drug SWOT Analysis
Table 48. Abbott Recent Developments
Table 49. Johnson and Johnson Monoclonal Antibody Drug Basic Information
Table 50. Johnson and Johnson Monoclonal Antibody Drug Product Overview
Table 51. Johnson and Johnson Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Johnson and Johnson Business Overview
Table 53. Johnson and Johnson Monoclonal Antibody Drug SWOT Analysis
Table 54. Johnson and Johnson Recent Developments
Table 55. Roche Monoclonal Antibody Drug Basic Information
Table 56. Roche Monoclonal Antibody Drug Product Overview
Table 57. Roche Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Roche Monoclonal Antibody Drug SWOT Analysis
Table 59. Roche Business Overview
Table 60. Roche Recent Developments
Table 61. Ono Pharmaceutical Monoclonal Antibody Drug Basic Information
Table 62. Ono Pharmaceutical Monoclonal Antibody Drug Product Overview
Table 63. Ono Pharmaceutical Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Ono Pharmaceutical Business Overview
Table 65. Ono Pharmaceutical Recent Developments
Table 66. Amgen Monoclonal Antibody Drug Basic Information
Table 67. Amgen Monoclonal Antibody Drug Product Overview
Table 68. Amgen Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Amgen Business Overview
Table 70. Amgen Recent Developments
Table 71. Merck Monoclonal Antibody Drug Basic Information
Table 72. Merck Monoclonal Antibody Drug Product Overview
Table 73. Merck Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Merck Business Overview
Table 75. Merck Recent Developments
Table 76. Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Basic Information
Table 77. Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Product Overview
Table 78. Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Jiangsu Hengrui Pharmaceuticals Business Overview
Table 80. Jiangsu Hengrui Pharmaceuticals Recent Developments
Table 81. Beigene Monoclonal Antibody Drug Basic Information
Table 82. Beigene Monoclonal Antibody Drug Product Overview
Table 83. Beigene Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Beigene Business Overview
Table 85. Beigene Recent Developments
Table 86. Shanghai Junshi Biosciences Monoclonal Antibody Drug Basic Information
Table 87. Shanghai Junshi Biosciences Monoclonal Antibody Drug Product Overview
Table 88. Shanghai Junshi Biosciences Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Shanghai Junshi Biosciences Business Overview
Table 90. Shanghai Junshi Biosciences Recent Developments
Table 91. Innovent Biologics Monoclonal Antibody Drug Basic Information
Table 92. Innovent Biologics Monoclonal Antibody Drug Product Overview
Table 93. Innovent Biologics Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Innovent Biologics Business Overview
Table 95. Innovent Biologics Recent Developments
Table 96. WuXi Biologics (Cayman) Monoclonal Antibody Drug Basic Information
Table 97. WuXi Biologics (Cayman) Monoclonal Antibody Drug Product Overview
Table 98. WuXi Biologics (Cayman) Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. WuXi Biologics (Cayman) Business Overview
Table 100. WuXi Biologics (Cayman) Recent Developments
Table 101. Shanghai Henlius Biotech Monoclonal Antibody Drug Basic Information
Table 102. Shanghai Henlius Biotech Monoclonal Antibody Drug Product Overview
Table 103. Shanghai Henlius Biotech Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Shanghai Henlius Biotech Business Overview
Table 105. Shanghai Henlius Biotech Recent Developments
Table 106. Akeso Monoclonal Antibody Drug Basic Information
Table 107. Akeso Monoclonal Antibody Drug Product Overview
Table 108. Akeso Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Akeso Business Overview
Table 110. Akeso Recent Developments
Table 111. Lepu Biopharma Monoclonal Antibody Drug Basic Information
Table 112. Lepu Biopharma Monoclonal Antibody Drug Product Overview
Table 113. Lepu Biopharma Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Lepu Biopharma Business Overview
Table 115. Lepu Biopharma Recent Developments
Table 116. CStone Pharmaceuticals Monoclonal Antibody Drug Basic Information
Table 117. CStone Pharmaceuticals Monoclonal Antibody Drug Product Overview
Table 118. CStone Pharmaceuticals Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. CStone Pharmaceuticals Business Overview
Table 120. CStone Pharmaceuticals Recent Developments
Table 121. Hillhouse Investment Management Monoclonal Antibody Drug Basic Information
Table 122. Hillhouse Investment Management Monoclonal Antibody Drug Product Overview
Table 123. Hillhouse Investment Management Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Hillhouse Investment Management Business Overview
Table 125. Hillhouse Investment Management Recent Developments
Table 126. Alphamab Oncology Monoclonal Antibody Drug Basic Information
Table 127. Alphamab Oncology Monoclonal Antibody Drug Product Overview
Table 128. Alphamab Oncology Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Alphamab Oncology Business Overview
Table 130. Alphamab Oncology Recent Developments
Table 131. Novartis Monoclonal Antibody Drug Basic Information
Table 132. Novartis Monoclonal Antibody Drug Product Overview
Table 133. Novartis Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Novartis Business Overview
Table 135. Novartis Recent Developments
Table 136. Takeda Pharmaceutical Monoclonal Antibody Drug Basic Information
Table 137. Takeda Pharmaceutical Monoclonal Antibody Drug Product Overview
Table 138. Takeda Pharmaceutical Monoclonal Antibody Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Takeda Pharmaceutical Business Overview
Table 140. Takeda Pharmaceutical Recent Developments
Table 141. Global Monoclonal Antibody Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 142. Global Monoclonal Antibody Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 143. North America Monoclonal Antibody Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 144. North America Monoclonal Antibody Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 145. Europe Monoclonal Antibody Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 146. Europe Monoclonal Antibody Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Asia Pacific Monoclonal Antibody Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 148. Asia Pacific Monoclonal Antibody Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 149. South America Monoclonal Antibody Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 150. South America Monoclonal Antibody Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 151. Middle East and Africa Monoclonal Antibody Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 152. Middle East and Africa Monoclonal Antibody Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 153. Global Monoclonal Antibody Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 154. Global Monoclonal Antibody Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 155. Global Monoclonal Antibody Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 156. Global Monoclonal Antibody Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 157. Global Monoclonal Antibody Drug Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Monoclonal Antibody Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Monoclonal Antibody Drug Market Size (M USD), 2019-2030
Figure 5. Global Monoclonal Antibody Drug Market Size (M USD) (2019-2030)
Figure 6. Global Monoclonal Antibody Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Monoclonal Antibody Drug Market Size by Country (M USD)
Figure 11. Monoclonal Antibody Drug Sales Share by Manufacturers in 2023
Figure 12. Global Monoclonal Antibody Drug Revenue Share by Manufacturers in 2023
Figure 13. Monoclonal Antibody Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Monoclonal Antibody Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Monoclonal Antibody Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Monoclonal Antibody Drug Market Share by Type
Figure 18. Sales Market Share of Monoclonal Antibody Drug by Type (2019-2024)
Figure 19. Sales Market Share of Monoclonal Antibody Drug by Type in 2023
Figure 20. Market Size Share of Monoclonal Antibody Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Monoclonal Antibody Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Monoclonal Antibody Drug Market Share by Application
Figure 24. Global Monoclonal Antibody Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Monoclonal Antibody Drug Sales Market Share by Application in 2023
Figure 26. Global Monoclonal Antibody Drug Market Share by Application (2019-2024)
Figure 27. Global Monoclonal Antibody Drug Market Share by Application in 2023
Figure 28. Global Monoclonal Antibody Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Monoclonal Antibody Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Monoclonal Antibody Drug Sales Market Share by Country in 2023
Figure 32. U.S. Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Monoclonal Antibody Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Monoclonal Antibody Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Monoclonal Antibody Drug Sales Market Share by Country in 2023
Figure 37. Germany Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Monoclonal Antibody Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Monoclonal Antibody Drug Sales Market Share by Region in 2023
Figure 44. China Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Monoclonal Antibody Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Monoclonal Antibody Drug Sales Market Share by Country in 2023
Figure 51. Brazil Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Monoclonal Antibody Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Monoclonal Antibody Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Monoclonal Antibody Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Monoclonal Antibody Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Monoclonal Antibody Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Monoclonal Antibody Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Monoclonal Antibody Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Monoclonal Antibody Drug Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Monoclonal Antibody Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Monoclonal Antibody Drug Market Size (M USD), 2019-2030
Figure 5. Global Monoclonal Antibody Drug Market Size (M USD) (2019-2030)
Figure 6. Global Monoclonal Antibody Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Monoclonal Antibody Drug Market Size by Country (M USD)
Figure 11. Monoclonal Antibody Drug Sales Share by Manufacturers in 2023
Figure 12. Global Monoclonal Antibody Drug Revenue Share by Manufacturers in 2023
Figure 13. Monoclonal Antibody Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Monoclonal Antibody Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Monoclonal Antibody Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Monoclonal Antibody Drug Market Share by Type
Figure 18. Sales Market Share of Monoclonal Antibody Drug by Type (2019-2024)
Figure 19. Sales Market Share of Monoclonal Antibody Drug by Type in 2023
Figure 20. Market Size Share of Monoclonal Antibody Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Monoclonal Antibody Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Monoclonal Antibody Drug Market Share by Application
Figure 24. Global Monoclonal Antibody Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Monoclonal Antibody Drug Sales Market Share by Application in 2023
Figure 26. Global Monoclonal Antibody Drug Market Share by Application (2019-2024)
Figure 27. Global Monoclonal Antibody Drug Market Share by Application in 2023
Figure 28. Global Monoclonal Antibody Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Monoclonal Antibody Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Monoclonal Antibody Drug Sales Market Share by Country in 2023
Figure 32. U.S. Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Monoclonal Antibody Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Monoclonal Antibody Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Monoclonal Antibody Drug Sales Market Share by Country in 2023
Figure 37. Germany Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Monoclonal Antibody Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Monoclonal Antibody Drug Sales Market Share by Region in 2023
Figure 44. China Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Monoclonal Antibody Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Monoclonal Antibody Drug Sales Market Share by Country in 2023
Figure 51. Brazil Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Monoclonal Antibody Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Monoclonal Antibody Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Monoclonal Antibody Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Monoclonal Antibody Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Monoclonal Antibody Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Monoclonal Antibody Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Monoclonal Antibody Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Monoclonal Antibody Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Monoclonal Antibody Drug Market Share Forecast by Application (2025-2030)
